MOHAMED ELHASSAN
Allopathic & Osteopathic Physicians|Hospitalist THE WOODLANDS, TX NPI 1669797940
Browse related groups: Allopathic & Osteopathic Physicians|Hospitalist TX Lilly USA, LLC All categories
General Payments — all program years on this page
$9,162.97
- Category: General Payments
- Program years: PY2018–2024
- Record count: 498
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,858.57 across 96 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,858.57 | 96 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $268.07 | 17 |
| Novo Nordisk AS | $263.49 | 15 |
| Corcept Therapeutics | $165.90 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $123.39 | 6 |
| Tandem Diabetes Care, Inc. | $123.21 | 5 |
| ABBVIE INC. | $103.51 | 5 |
| Amgen Inc. | $88.87 | 5 |
| Radius Health, Inc. | $64.80 | 4 |
| Xeris Pharmaceuticals, Inc. | $63.45 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.77 | 3 |
| SANOFI-AVENTIS U.S. LLC | $54.18 | 2 |
| Insulet Corporation | $52.29 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $46.42 | 2 |
| Averitas Pharma Inc. | $46.28 | 3 |
| Medtronic, Inc. | $45.91 | 1 |
| Kyowa Kirin, Inc. | $37.74 | 2 |
| DEXCOM, INC. | $34.31 | 2 |
| Esperion Therapeutics, Inc. | $31.71 | 2 |
| CeQur Corporation | $31.15 | 1 |
| Astellas Pharma US Inc | $23.80 | 1 |
| Amneal Pharmaceuticals LLC | $23.66 | 1 |
| Abbott Laboratories | $20.72 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $20.53 | 1 |
| Endo Pharmaceuticals Inc. | $18.89 | 1 |
| Antares Pharma, Inc. | $18.76 | 1 |
| Acella Pharmaceuticals, LLC | $15.12 | 1 |
| MannKind Corporation | $14.64 | 1 |
By program year
Records — PY2024 (96)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.